IQP-0304

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameIQP-0304
Drug Alias Namepiperazine derivative (Samjin/ImQuest)SJ-3249IQP-0304
ClassificationSmall molecules
Mechanisms of ActionCell cycle inhibitorsApoptosis modulatorsMicrotubule inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSamjin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImQuest Life Sciences IncSamjin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A